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In Brief
Kennedy et al. describe a mouse model
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intellectual disability caused by
haploinsufficiency of the transcription
factor Tcf4. RNA-seq and MBD-seq of
hippocampal tissue reveal broad
dysregulation in the transcription and
DNA methylation of memory-related
genes and identify Hdac2 inhibition as a
potential therapy for Pitt-Hopkins
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Human haploinsufficiency of the transcription factor
Tcf4 leads to a rare autism spectrum disorder called
Pitt-Hopkins syndrome (PTHS), which is associated
with severe language impairment and development
delay. Here, we demonstrate that Tcf4 haploin-
sufficient mice have deficits in social interaction, ul-
trasonic vocalization, prepulse inhibition, and spatial
and associative learning and memory. Despite
learning deficits, Tcf4(+/) mice have enhanced
long-term potentiation in the CA1 area of the hippo-
campus. In translationally oriented studies, we found
that small-molecule HDAC inhibitors normalized hip-
pocampal LTP and memory recall. A comprehensive
set of next-generation sequencing experiments of
hippocampal mRNA and methylated DNA isolated
from Tcf4-deficient and WT mice before or shortly
after experiential learning, with or without admin-
istration of vorinostat, identified ‘‘memory-associ-
ated’’ genes modulated by HDAC inhibition and
dysregulated by Tcf4 haploinsufficiency. Finally,
we observed that Hdac2 isoform-selective knock-
down was sufficient to rescue memory deficits in
Tcf4(+/) mice.INTRODUCTION
Transcription factor 4 (Tcf4 aka E2-2, ITF-2, and SEF-2) is
necessary for neurodevelopment and plays an important role
in cognition, being associated with both schizophrenia and
autism-spectrum intellectual disability (ID) (Forrest et al., 2014;
Sweatt, 2013). Tcf4 also has an intimate relationship with verbal
memory and language development. A series of intronic SNPs in
the Tcf4 locus have been identified by genome-wide association2666 Cell Reports 16, 2666–2685, September 6, 2016 ª 2016 The Au
This is an open access article under the CC BY license (http://creativestudies as highly correlative with schizophrenia. The Tcf4
rs9960767 SNP disrupts sensory-motor gating in both schizo-
phrenia-spectrum and healthy volunteers alike and en-
hances verbal memory in schizophrenic patients that carry the
rs9960767 risk allele without measurably affecting attention
and executive function (Lennertz et al., 2011; Quednow et al.,
2011). Loss-of-function mutations in Tcf4 lead to the near-com-
plete lack of language acquisition and cause the rare ID known
as Pitt-Hopkins syndrome (PTHS). Altogether, it is likely that
Tcf4 regulation of CNS gene transcription is an underlying
process in language comprehension, production, and recall.
As amember of the basic helix-loop-helix (bHLH) transcription
factor structural family known as E proteins, Tcf4 recognizes the
Ephrussi box (E-Box) DNA element (50-CANNTG-30). Tcf4 affects
chromatin remolding and transcription through the recruitment
of histone acetyltransferases (HATs) such as p300 (Bayly et al.,
2004; Massari et al., 1999; Zhang et al., 2004). Tcf4 binds the
pseudo-palindromic E-Box via homo-dimerization or hetero-
dimerization with other bHLH transcription factors. PTHS muta-
tions occur almost exclusively in the bHLH domain of Tcf4,
mutating basic residues that are necessary for DNA association
or that disrupt bHLH dimerization (Sepp et al., 2012) and lead-
ing to a loss-of-function and Tcf4 haploinsufficiency. PTHS
[Tcf4(+/)] is characterized by ID, pronounced developmental
delay, lack of motor coordination, epilepsy, breathing abnormal-
ities, autistic behaviors, and language impairment, in most cases
with little to no language usage throughout the lifespan (de Pon-
tual et al., 2009; Ghosh et al., 2012; Peippo and Ignatius, 2012).
Few studies have addressed treatment, and currently there is no
effective therapy for the cognitive deficits of PTHS (Blake et al.,
2010; Zweier et al., 2008). Valproate has been prescribed to treat
the epileptic seizures often incurred by PTHS, and one report
noted improvement of breathing abnormalities after valproate
(Maini et al., 2012). This is intriguing, because one of valproate’s
mechanisms of action is HDAC inhibition, and a major role of
Tcf4 appears to be the regulation of histone acetylation state.
As an aside, it is important to distinguish Tcf4 from the immune
cell regulator T cell factor 4 (Tcf7l2), member of the TCF/LEFthor(s).
commons.org/licenses/by/4.0/).
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Figure 1. Tcf4(+/) Mice Are Hyperactive, Display Motor Incoordination, Have Reduced Prepulse Inhibition, and Show Autistic-like Behavior
(A) Homology model of Tcf4 protein (teal) with NeuroD2 (tan) bound to DNA. Mutations in Tcf4 protein that cause PTHS (yellow) are predominately basic residues
necessary for DNA backbone association.
(B and C) Open field. Distance traveled per minute during a 30 m trial. Tcf4(+/) mice show hyperactivity and a reduced ability to habituate to an open field.
(D) Thigmotaxis, a behavior associated with anxiety, during the open field task.
(E and F) Elevated plus maze. Arm entries during a 5 m trial. Tcf4(+/) mice cross more frequently between arms but do not elicit significantly altered anxiety
toward open arms.
(G) Dynamic weight bearing. Tcf4(+/) mice place more body weight on the front left paw than on the front right.
(H) Representative images of Tcf4(+/) mice placing more pressure on the front left paw than on the front right while ambulating across a catwalk.
(I) Three-chamber social interaction task. Mice are placed into the center (C) of a three-chamber apparatus, where the distal chambers contained either an empty
cylindrical cage (E) or a cylindrical cage holding a novel mouse (M) of equivalent age, gender, and strain. Tcf4(+/) mice show social aversion, preferring the
chamber with an empty cage to that with the novel mouse.
(legend continued on next page)
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family of transcription factors and commonly, and erroneously,
referred to as TCF4 in the literature.
Two genes, Nrxn1 and Cntnap2, both in the neurexin family of
cell adhesion molecules, are believed to be downstream targets
of Tcf4, because the knockout of either leads to a phenotype
similar to that of PTHS, known as PTHS-like 1 and 2, respec-
tively. However, little else is known about the transcriptional con-
sequences of Tcf4 haploinsufficiency in the brain or whether Tcf4
affects synaptic plasticity and hippocampal function associated
with learning and memory. To begin investigating Tcf4 function
in cognition, we first characterized a PTHSmousemodel for def-
icits in memory and dysregulated synaptic plasticity in the hippo-
campus. Thus, we would have a model to test the transcriptional
and epigenetic mechanisms dysregulated by Tcf4 haploinsuffi-
ciency and test the hypothesis that HDAC inhibition is a thera-
peutic route to treat the cognitive deficits associated with PTHS.
RESULTS
Tcf4(+/) Mouse Models PTHS
To further understanding of the neurobiological consequences of
Tcf4 haploinsufficiency, we assessed a Tcf4(+/) mouse with a
deletion of the exons that code for the bHLH domain as a poten-
tial model for PTHS (Grubisic et al., 2015; Zhuang et al., 1996).
Approximately seven out of ten PTHS cases are caused by
SNPs that generate a premature stop codon or a point mutation
in the bHLH domain of Tcf4 protein (Sepp et al., 2012), disrupting
either transcription factor dimerization or mutating one of the
basic residues required for DNA backbone association (Fig-
ure 1A). The concentration of PTHSSNPs in the bHLHmotif high-
lights a more specific molecular feature of PTHS, namely, the
loss of Tcf4 protein and DNA association, and distinguishes
them from other SNPs elsewhere in the Tcf4 locus that are
strongly associated with schizophrenia. The Tcf4(+/) mouse
should therefore be a functional model of PTHS rather than
schizophrenia per se, because the coding region for the bHLH
domain has been deleted.
A behavioral battery was undertaken to determine whether
Tcf4(+/) mice have motor control differences, have learning
and memory deficits, or display behavior akin to other rodent
models of autism spectrum disorders (ASDs). Tcf4(+/) mice
show no apparent increase in anxiety, as assessed by an open
field task and the elevated plus maze; however, both paradigms
detect a significant increase in activity (Figures 1B–1F). When
placed in an open field, Tcf4(+/) mice have no significant differ-
ence in ambulation during the first minute block of the 30 min
trial. However, as the experiment continues, they have consis-
tently higher activity without affecting the overall time spent in
the center of the field. Hyperactivity was also detected in the
elevated plus maze, where Tcf4(+/) mice show an increase in(J) Start reflex. Tcf4(+/) mice have an enhance startle reflex to unexpected 120
(K) Tcf4(+/) mice have deficits in prepulse inhibition of the startle reflex when t
background white noise.
(L) USVs in Tcf4(+/) pups P3 and P5 were significantly infrequent when remove
(M and N) Occurrence (M) and traces (N) across ultrasonic frequencies elicited b
All data shown are means ± SEM from 12 mice per genotype at 2–3 months of age
(P3–P11) and 6 mice per genotype. *p < 0.05, **p < 0.01, ***p < 0.001.
2668 Cell Reports 16, 2666–2685, September 6, 2016overall arm entrances without spending a significantly increased
amount of time in the open arms.
PTHSpatients havemarked problemswithmotor coordination
and balance, and we hypothesized that Tcf4(+/) mice would
exhibit similar deficits in balance and motor control or learning.
We found that Tcf4(+/) mice had asymmetry in their motor con-
trol and an imbalance that favors their left side. Dynamic weight
bearing, which is the measure of how much force is placed on
each paw at rest, was used to assess balance, and Tcf4(+/)
mice placed significantly more weight on their front left paw
than their right (Figure 1G). Similarly, Tcf4(+/) mice favored their
front left paw while ambulating across a catwalk. Figure 1H con-
tains representative images of front-paw pressures collected
during the catwalk assessment, where the heatmap indicates
the pressure gradient across the paw. In both experiments,
Tcf4(+/) mice significantly underuse their front right paw rela-
tive to their left and relative to the front right paws of wild-type
(WT) controls (Figure S1). In addition, Tcf4(+/) mice show
significantly weaker hindlimb, but not forelimb, grip strength
(Figure S2).
To determine whether there were deficits with coordination
and motor learning in performing more challenging tasks,
Tcf4(+/) mice were also made to walk across a horizontal lad-
der and balance on a rotating rod (Figure S2). The horizontal
ladder task assesses the time required for the animal to transit
the ladder and measures the number of errors the animals com-
mits in the process in the form of missing a rung of the ladder.
The rotating rod task measures coordination, as well as motor
learning and memory, because the task is repeated over the
course of several trials and days. The Tcf4(+/) mice showed
no significant difference in the performance of either test, sug-
gesting that while there are balance and coordination asymme-
tries, those deficits are not sufficient to impair performance on
activity-dependent tasks.
PTHS is an ASD with the predominant phenotype of severe
language impairment, and mouse models of ASDs have shown
deficits in social interactions (Roullet and Crawley, 2011). To
determine whether Tcf4(+/) mice display social aversion or
indifference, test mice were submitted to a three-chamber
experiment, wherein the distal chambers contained either an
empty cylindrical cage or a cylindrical cage holding a novel
mouse of equivalent age, gender, and strain. Neurotypical
mouse behavior favors social interaction over isolation, and
WT controls held in isolation for 10 days spend significantly
more time in the chamber holding the novel mouse than that
with the empty cage (Crawley, 2004); however, Tcf4(+/) mice
preferred social isolation over interaction (Figure 1I). In addition,
ASD mouse models often display repetitive behaviors, including
increased grooming (Crawley, 2012), and Tcf4(+/) mice
groom themselves significantly more than WT mice (Figure S2).dB sound bursts.
he 120 dB sound burst is preempted by 69, 73, and 81 dB pulses over 65 dB
d from the nest.
y P3 pups.
, with the exception of the USV experiments, which were performed with pups
Tcf4(+/) mice are hyperreflexive and have significant deficits
in prepulse inhibition, highlighting the connection between Tcf4
and schizophrenia and autism, because a feature of these disor-
ders is dysregulation of sensorimotor gating (Figures 1J and 1K).
Loss-of-function mutations in other transcription factors
important in language development, most notably FOXP2,
causes a reduction in ultrasonic vocalizations (USVs) for young
pups when they are removed from the nest (Fujita et al., 2008;
Shu et al., 2005). When pups (post-natal day 3, or P3) are
removed from the nest, they elicit USVs as a mechanism meant
to notify their mother, a process believed to have cognitive sim-
ilarities to those processes that underlie language in humans.
Tcf4(+/) pups (P3) have significantly reduced USV occurrence,
which remains low until the phenotype converges with normal
behavior or WT controls around P7 (Figures 1L and 1M; Fig-
ure S3). Tcf4(+/) pups (P3) also have significantly weaker calls
whenmeasuring themaximumpressure (in decibels) between 20
and 100 kHz during the 5min test window (Figure 1N). Like spon-
taneous USVs, ultrasonic distress calls are similarly less frequent
and at lower volumes at 3 days of age for Tcf4(+/) pups
(Figure S4).
To determine whether the Tcf4(+/) mouse model shows the
cognitive deficits associated with PTHS, we assessed their
spatial and associative learning and memory using behavioral
paradigms. The Morris water maze (MWM) is a classic hippo-
campus-dependent task that is used to evaluate spatial learning
and memory. The MWM consists of teaching a rodent to use
distal visual cues to locate a hidden platform just beneath the
surface of the water in a circular pool. At first, the mouse finds
the platform by chance, but after several subsequent trials, the
mouse learns to use the visual cues present to locate the plat-
form from several starting points at the pool’s edge. After
training, 24 hr memory was tested by removing the platform
from the pool, measuring the amount of time spent in the quad-
rant in which the platform was located, and counting the number
of occurrences wherein the mouse crosses over the platform
zone during a 60 s trial. Tcf4(+/) mice failed to show selec-
tivity for the target quadrant, spending significantly less time
there than did theWTmice and crossing the platform zone signif-
icantly fewer times (Figures 2A–2C), despite having unimpaired
visible-platform learning and similar average swim speed (Fig-
ure S2). Similarly, Tcf4(+/) mice have a significant deficit in
24 hr object location memory (OLM), another hippocampus-
dependent spatial memory task (Figure 2D). Mice were given
10 min to interact with two equivalent 50 ml beakers. Memory
was assessed by moving one of the beakers to a novel location
of the test chamber and measuring the amount of time the test
mouse expressed interest in that beaker compared with the
beaker in the familiar location over a 5 min test. Altogether, the
MWMandOLM tasks elucidate a profound impairment of spatial
learning and memory in Tcf4(+/) mice.
We also performed tests of contextual and trace threat recog-
nition training, known as classical fear conditioning, to assess
hippocampus-dependent associative learning and memory. In
threat recognition training, a conditioned stimulus (CS), a tone
and/or context, is paired with an unconditioned stimulus (US),
a mild foot shock. Learning and memory is then assessed by
measuring the freeze response caused by re-exposure to thetraining context or to the cue presented in a novel context. For
our experiments, a ‘‘trace’’ protocol was used to pair three white
noise tones (CS) with a foot shock (US) presented 15 s after the
end of the CS (Figure 2E), and then contextual and cued tests
were performed 24 hr after training (Figures 2F and 2G). The
contextual and trace cued tests are hippocampus-dependent
associations, and Tcf4(+/) mice showed significantly reduced
freezing in both.
Given the observation that Tcf4(+/) mice have deficits in hip-
pocampus-dependent learning and memory paradigms, we ex-
pected that long-term potentiation (LTP) at Schaffer collaterals
betweenCA3 andCA1 in the hippocampuswould be attenuated,
because LTP in the hippocampus is known to subserve learning
in these tasks. Surprisingly, we found that Tcf4(+/) mice have
enhanced Schaffer collateral LTP when activated with theta
burst stimulation (Figure 2H). Enhanced LTP coupled with
learning and memory deficits is uncommon but not unprece-
dented for models of ID (Gu et al., 2002).
Altogether, these baseline assessments of behavior and elec-
trophysiology strongly support the notion that the Tcf4(+/)
mouse model the phenotype presented in PTHS. We next used
themodel to probe for potential downstream transcriptional con-
sequences of PTHS, determine the effects on broad epigenetic
regulation due to Tcf4 haploinsufficiency, and screen potential
neurotherapeutics.
Tcf4 Regulates Gene Transcription in the Hippocampus
Having characterized the deficits in learning andmemory caused
by Tcf4 haploinsufficiency, it was of interest to identify down-
stream transcriptional targets of Tcf4 in the hippocampus. We
performed poly(A)+ RNA sequencing on hippocampal CA1
tissue from naive Tcf4(+/) mice and WT controls. Using
Cufflinks analysis, we determined 402 differentially expressed
genes (DEGs) at a false discovery rate (FDR) of 0.05 (Figure 3A;
Table S1). After annotating these DEGs through the Kyoto Ency-
clopedia of Genes and Genomes (KEGG) pathway database, we
found that significant dysregulation occurred in biochemical
pathways associated with neuronal plasticity, including axon
guidance, cell adhesion, calcium signaling, and most promi-
nently, neuroreceptors (Figures 3E and 3F). We hypothesized ef-
fects on cell adhesion pathways could be occurring through the
neurexins Nrxn1 and Cntnap2, given their potential relationship
to Tcf4. However, the expression of these PTHS-associated
genes was not affected by Tcf4(+/) (Figure 3B). The binding
partner for Cntnap2, Cntn2, was significantly downregulated.
More than half of the identified DEGs code for membrane-
associated proteins that include a large concentration of neuro-
receptors, many of which are upregulated (Figure 3B). This
includes genes that govern the signaling of dopamine (Drd1a,
Cckbr, and Chrm4), oxytocin (Oxtr), serotonin (Htr2c), glycine
(Glra2 and Glra3), and neuromedin B (Nmbr), suggesting Tcf4
plays an important role in the negative regulation of these neuro-
transmitters in the hippocampus, although altered RNA stability
or processing could also contribute to our observed effects.
Conversely, other signaling pathways important in learning and
memory are downregulated, such as NMDA receptor (NMDAR)
subunit 2a (Grin2a), neuropeptide Y receptor (Npy2r), and a
pair of lysophospholipid receptors (Lpar1 and S1pr5). AnotherCell Reports 16, 2666–2685, September 6, 2016 2669
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Figure 2. Tcf4(+/) Mice Have Deficits in Associative and Spatial Learning and Memory, Prepulse Inhibition, and Enhanced LTP across
Schaffer Collaterals
(A–C) MWM hidden platform task. Tcf4(+/) mice show reduced spatial learning in locating the hidden platform.
(D) 24 hr OLM.Mice interacted for 10minwith 50ml beakers, and 24 hrmemory was tested bymoving one beaker to a novel location andmeasuring the amount of
time interacting with the novel location (tN) versus the familiar location (tF). Discrimination index = (tN  tF)/(tN 3 tF).
(E) Trace threat recognition training. Mice were presented with a 30 s white noise tone (CS, line), followed by a 15 s delay, and then a 1 s, 0.5 mA foot shock (US,
arrow) three times over the course of a 7.5 m trial. Tcf4(+/) mice do not show deficits in freezing during training.
(F) 24 hr contextual test. Tcf4(+/) mice show reduced freezing during a 5 m test in the training context.
(G) 24 hr cued test. Tcf4(+/) mice show reduced freezing when placed in a novel context and presented with a 3 m white noise tone.
(H) Tcf4(+/) mice have enhanced LTP across Schaffer collaterals when activated with (13) theta burst stimulation.
All data shown are means ± SEM from 6–12 mice per genotype at 2–3 months of age. LTP from 55–58 hippocampal slices per group. *p < 0.05, **p < 0.01,
***p < 0.001.family of DEGs identified, and annotated by phenotype, is those
genes that are known to regulate myelination (Figure 3B). Myeli-
nation states and oligodendrocyte differentiation have been
implicated for some time in synaptic plasticity (Fields, 2005)
and schizophrenia (Lee and Fields, 2009). All DEGs associated
with myelination are downregulated.
Besides the large families of DEGs, other individual genes of
interest were mined from the RNA sequencing (RNA-seq) data.
Klotho (Kl), a membrane protein that has been identified as an
enhancer of LTP in mice and associated with improved cognition
in humans (Dubal et al., 2014), was found to be upregulated. Arc
is a well-known immediate early gene (IEG) that plays an impor-
tant role in synaptic plasticity, information processing, and
memory (Shepherd and Bear, 2011) and was found to be signif-2670 Cell Reports 16, 2666–2685, September 6, 2016icantly downregulated. What precisely Arc deficiency means for
Tcf4(+/) naive mice is not entirely clear; however, Arc has been
shown to negatively regulate AMPA receptor trafficking to the
synapse and affect homeostatic scaling while neurons are held
at rest with tetrodotoxin (Shepherd et al., 2006), which may
help explain the observed enhancement in LTP. Lefty1, a
member of the Nodal signaling pathway, is also significantly
downregulated. Lefty1 is predominantly expressed in the left
hemisphere, including the hippocampus, and along with other
members of the Nodal family, is responsible for many left-right
asymmetries. Given that Tcf4(+/) mice have weak front right
paws and humans with PTHS have such stark language deficits,
Lefty1 is an interesting candidate as an effector of these pheno-
types downstream from Tcf4.
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Figure 3. Gene Expression Patterns and Altered CpG Methylation Caused by Tcf4(+/) in the Hippocampus
(A) Heatmap of poly(A) RNA-seq DEGs in the Tcf4(+/) hippocampus showing individual replicates (FDR < 0.05).
(B) Gene expression grouped by their relation to PTHS, neuroactive receptors, andmyelination (blue, downregulated; orange, upregulated; white, not significant).
(C) Relative global methylation across gene bodies. Curve thickness is ±SEM.
(D) DEG gene body and TSS methylation changes.
(E) Top ten represented upregulated KEGG pathways in Tcf4(+/) mice as ranked by Benjamini and Hochberg (B-H) adjusted p value.
(F) Downregulated KEGG pathways in Tcf4(+/) mice.
(G) In Tcf4(+/) hippocampal tissue, 97 deregulated genes are affected by the administration of the class I Hdac inhibitor CI-994 and have a strong negative
correlation (R2 = 0.72).
All data shown are from four mice per genotype at 2 months of age.Tcf4(+/) Results in Altered DNA Methylation
DNA methylation has been shown to regulate chromatin organi-
zation, gene expression, synaptic plasticity, and memory and is
a putative mechanism for long-term transcriptional regulation in
neurons (Day et al., 2015; Gra¨ff et al., 2011; Kennedy and Sweatt,
2016; Shin et al., 2014; Tsankova et al., 2007). To determine the
potential dysregulation of genome-wide CpG methylation in the
CA1 area of the hippocampus of Tcf4(+/) mice, DNA extracted
from the CA1 area was fragmented to lengths between 200 and
300 bp by sonication and methylated DNA sequestered by
Methyl-CpG-binding domain protein 2 (MBD) association, whichdetects CpG dimethylation but not hemi-methylation or oxidized
methylcytosine species (Aberg et al., 2012). These CpG-methyl-
ated DNA fragments (between 6% and 9%of all fragments) were
then sequenced and mapped to the mouse genome (mm10) us-
ing the Bowtie 2.0 algorithm. In general, CpG methylation in the
gene promoter inhibits gene transcription directly through the
inhibition of transcription factor binding or by enhancing local
chromatin organization around the transcription start site (TSS)
via MBD binding and HDAC recruitment (Tan and Nakielny,
2006). Gene body CpG methylation is more enigmatic, with
both transcript elongation and splicing effects documentedCell Reports 16, 2666–2685, September 6, 2016 2671
(Jones, 2012). To first assess global CpG methylation trends,
read density around genes was plotted (Figure 3C). Tcf4(+/)
mice have similar global methylation patterns across promoter
regions but reducedmethylation of across all gene bodies. How-
ever, changes in methylation are not uniform across all genes,
and demethylation is significantly associated with upregulated
DEGs, both at TSSs and gene bodies, but not with downregu-
lated genes (Figure 3D).
To determine specific loci of differential genome methylation,
individual sites of CpG methylation along the genome were
identified using a genome-wide differential coverage analysis
designed for Methyl-CpG-binding domain protein 2 sequencing
(MBD-seq)-like data (Lienhard et al., 2014). The mm10 genome
was divided into 300 nt windows, datasets were normalized us-
ing quantile normalization, and differential coverage was calcu-
lated using edgeR statistical analysis in the context of CpG
density. Using this analysis, Tcf4(+/) hippocampal tissue was
found to have 734 differentially methylated regions (DMRs) at a
FDR of 0.1 (Table S2). Select DMRs were then confirmed
to have altered CpGmethylation at the single nucleotide level us-
ing bisulfite sequencing from the same biological replicates
(Figure S5).
HDAC Inhibition Normalizes LTP and Rescues Memory
Given the breadth of transcriptional dysregulation due to Tcf4
haploinsufficiency, we considered therapeutic mechanisms
that more broadly affect gene transcription. One such candidate
that has already found success in improving learning and mem-
ory is HDAC inhibition, which has been shown to enhance LTP,
improve learning and memory, and ameliorate memory deficits
in models of Alzheimer’s disease (Fischer et al., 2007; Kilgore
et al., 2010). This was particularly appealing given the role Tcf4
plays in regulating histone acetylation by attracting either HATs
or an HDAC-bound nuclear suppressor complex to TSSs. The
HDAC inhibitor CI-994 has been shown to improve memory
extinction after threat recognition training in mice (Gra¨ff et al.,
2014). In this prior study, mice were trained and treated with
CI-994 and RNA-seq was performed on tissue extracted from
the hippocampus post-extinction. To assess the therapeutic
potential of HDAC inhibition for PTHS, the published gene
expression profiles from CI-994 treatment were compared to
our newly acquired data. Figure 3G shows the significant overlap
(p < 2.7 3 1076, representation factor = 11.8) of 97 DEGs be-
tween the Tcf4(+/) and CI-994 datasets (Table S3). Nearly
one-quarter of the genes dysregulated in the Tcf4(+/) mice
are also regulated by HDAC inhibition. The strong negative
correlation between Tcf4(+/) and CI-994 DEGs (R2 = 0.72)
suggests HDAC inhibition is a viable avenue for correcting a large
percentage of transcriptional dysregulation associated with Tcf4
haploinsufficiency.
To determine whether HDAC inhibition would be sufficient to
normalize synaptic plasticity in the CA1 area of the hippocampus
of Tcf4(+/) mice, LTP studies of Schaffer collaterals were
performed after incubating the hippocampal slice with the
HDAC inhibitor Trichostatin A (TSA) for 20 min before theta burst
stimulation (Figures 4A–4C). In other models with cognitive def-
icits, and with WT mice, HDAC inhibition has been associated
with enhanced LTP in theCA1 area, an effect that can be blocked2672 Cell Reports 16, 2666–2685, September 6, 2016by inhibitors of transcription and those of active DNAmethylation
(Miller et al., 2008). It was therefore unclear whether TSA
treatment would similarly increase the already enhanced LTP
observed in Tcf4(+/) mice. Surprisingly, TSA treatment signifi-
cantly reduced LTP in the Tcf4(+/) hippocampus, even though
there is ameasured increase in LTP for TSA-treatedWT controls.
This observed reduction in LTP mediated by HDAC inhibition in
the CA1 area of the Tcf4(+/) mice, albeit unexpected, had the
effect of normalizing the LTP magnitude to that of untreated
WT controls (Figure 4C).
These LTP results prompted us to test the hypothesis that
HDAC inhibition would be effective in improving cognition in
PTHS model mice. Tcf4(+/) mice were treated subchronically
with suberoylanilide hydroxamic acid (SAHA; vorinostat, Zolinza)
at 25 mg/kg once per day intraperitoneally (i.p.) for 10 days
before behavioral assessment. SAHA did not measurably affect
activity or anxiety in WT or Tcf4(+/) mice (Figures 4D and 4E).
The SAHA-treated Tcf4(+/) mice, along with vehicle and WT
controls, were then submitted to the threat recognition training
protocol described earlier, and contextual and cued tests were
performed 24 hr after training (Figures 4F and 4G). Subchronic
administration of SAHA was sufficient to rescue memory-asso-
ciated freezing in Tcf4(+/) mice to levels observed in the
contextual and cued tests for WT mice. Altogether, these results
indicate that HDAC inhibitor treatment improves learning and
memory in Tcf4(+/) mice through the normalization of synaptic
plasticity.
The enhancement in LTP and the strong correlation between
the Tcf4(+/) DEGs and those genes differentially expressed
by HDAC inhibition after memory recall (Figure 3G) led us to
wonder whether learned information was being at least tempo-
rarily consolidated but rendered inaccessible or impermanent
by hyperplasticity. Consequently, Tcf4(+/) mice were trained
using the trace threat recognition protocol, in which awhite noise
tone (CS) is presented 15 s before a 0.5 mA foot shock (US) for a
total of three pairings (Figure 4H). Trace conditioning caused by
this protocol is optimal in this case, because it has been shown
to be dependent on NMDAR activity in the CA1 area (Quinn et al.,
2005). A cue test was then performed 24 hr after training to
assess memory recall, after which Tcf4(+/) mice were treated
daily with SAHA for 10 days before being submitted to a second
cue test. Tcf4(+/) mice exhibited reduced freezing when pre-
sented with the CS in a novel context 24 hr after training (Fig-
ure 4I); however, after SAHA treatment, memory was rescued
to WT levels and significantly increased over Tcf4(+/) vehicle
controls (Figure 4J). This HDAC inhibitor-mediated restoration
of a previously irretrievable memory is surprising but not unprec-
edented—similar results were obtained in studies of a mouse
neurodegeneration model (Fischer et al., 2007). Overall, these
data suggest a strong potential for HDAC inhibitors as therapeu-
tics for improving cognition and memory recall in PTHS.
Tcf4(+/) Affects theExpression andDNAMethylation of
Memory-Associated Genes
Several Tcf4(+/) DEGs, notably Arc and Grin2a, are known to
be important in long-termmemory formation. However, to better
understand the scope Tcf4 plays in regulating memory-associ-
ated genes and to test whether SAHA affects the expression of
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Figure 4. HDAC Inhibition Rescues LTP and Memory in Tcf4(+/) Mice
(A) TSA reduces LTP in the CA1 area of Tcf4(+/) mice.
(B) TSA enhances LTP in the CA1 area of WT controls.
(C) TSA normalizes LTP in Tcf4(+/) mice relative to untreated WT controls.
(D and E) SAHA has no significant effect on Tcf4(+/) hyperactivity or thigmotaxis in an open field.
(F and G) SAHA administered 25 mg/kg i.p. for 10 days rescues Tcf4(+/) deficits in 24 hr contextual and trace-cued threat recognition memory.
(legend continued on next page)
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these genes in the hippocampus, a series of next-generation
sequencing experiments was conducted on Tcf4(+/) hippo-
campal tissue shortly after threat recognition training, with and
without the administration of SAHA. Tcf4(+/) and WT were
treated with SAHA or vehicle for 10 days and then either trained
using the trace threat recognition protocol described previously
or kept naive. The mice were sacrificed 1 hr after training, and
RNA and DNA were extracted from the CA1 region of the hippo-
campus (Figure 5A). As with the untreated and untrained
sequencing experiments, poly(A)+ RNA-seq and MBD-seq
were performed to determine the genome-wide changes in
gene transcription and DNA methylation induced by experiential
learning andmodulated by subchronic SAHA injection, aswell as
how these dynamics are affected by Tcf4(+/).
First, an analysis of DEGs between the Tcf4(+/) naive vehicle
andWT naive vehicle groups was performed to validate the orig-
inal RNA-seq study. Comparing the original 402 Tcf4(+/) DEGs
to the 529 Tcf4(+/) naive vehicle DEGs shows a highly signifi-
cant and correlative overlap of 199 genes that were indepen-
dently identified in both sequencing experiments (Figure 5B).
This degree of similarity for the untreated and vehicle Tcf4(+/)
groups versus their respective controls demonstrates the
reproducibility of these sequencing experiments. In addition,
Fischer’s meta-analysis was performed across these datasets
to combine p values and generate a more confident list of 678
genes dysregulated in the hippocampal CA1 area of Tcf4(+/)
mice (Table S4).
These data also allow the identification of 1,517 memory-
associated genes that have altered transcription after threat
recognition training by comparing the expression of theWT naive
vehicle group to that of WT trained vehicle group (Figure 5C;
Table S5), including well-characterized IEGs that are upregu-
lated shortly after learning, such as Arc, Fos, and Egr2, and
genes that are downregulated after experiential learning, such
as Grin2a andMalat1. Cross-comparing the DEGs identified be-
tween each of the seven most relevant pairwise comparisons
(trained, WT trained vehicle versus WT naive vehicle; SAHA,
WT naive SAHA versus WT naive vehicle; trained SAHA, WT
trained SAHA versus WT naive SAHA; Tcf4(+/), Tcf4(+/) naive
vehicle versus WT naive vehicle; Tcf4(+/) trained, Tcf4(+/)
trained vehicle versus Tcf4(+/); Tcf4(+/) SAHA, Tcf4(+/)
naive SAHA versus Tcf4(+/) naive vehicle; Tcf4(+/) trained
SAHA, Tcf4(+/) trained SAHA versus Tcf4(+/) naive SAHA)
in a chord diagram illustrates those DEG lists with high degrees
of overlapping gene identities (Figure 5D; Table S6). The stron-
gest degree of overlap is between the two trained gene lists for
WT and Tcf4(+/), demonstrating that 414 of the 1,517 mem-
ory-associated genes are also being activated in Tcf4(+/)
mice after experiential learning. However, the association that
stood out the most was the 217 DEGs that overlap between
the trained and the Tcf4(+/) gene lists (p = 3.4 3 1087), con-
firming that Tcf4 regulates a large number of genes that are(H) Schematic of the experimental paradigm to test SAHA-mediatedmemory retrie
protocol, tested for memory at 24 hr, and then treated with SAHA for 10 days be
(I) Tcf4(+/) mice have 24 hr memory deficits. Bars represent freezing during the
(J) SAHA treatment after training improves remote memory recall in Tcf4(+/) mi
All data shown are means ± SEM from six mice per group at 2 months of age. *p
2674 Cell Reports 16, 2666–2685, September 6, 2016actively regulated by learning. Both the trained and the
Tcf4(+/) DEGs are also closely related to those genes with
expression altered by treatment with SAHA, highlighting the
interconnected relationship among Tcf4, HDAC inhibition, and
memory formation at the level of gene expression.
Analyzing the expression of individual genes across these
datasets, especially Tcf4(+/) DEGs, should provide insight
into how HDAC inhibition, an epigenetic therapy that broadly af-
fects transcription, improves learning and memory in Tcf4(+/)
mice (Figure 5E). Tcf4 trends toward decreased expression after
training in both WT and Tcf4(+/) mice (Fischer’s combined p <
0.02). SAHA administration does not profoundly affect Tcf4
expression in WT or Tcf4(+/) mice; however, there are small,
yet significant, changes in Tcf4 expression in Tcf4(+/) mice
after training compared to vehicle controls at the level of individ-
ual transcripts (Figure S6). Grin2a, downregulated in Tcf4(+/)
mice, is also downregulated after training (Figure 5E). SAHA
administration significantly increases Grin2a gene expression
in Tcf4(+/) mice compared to vehicle controls. However, not
all Tcf4(+/) DEGs responded to SAHA treatment. For example,
Arc, a downregulated Tcf4(+/) DEG and an IEG, is unaffected
by SAHA in Tcf4(+/) mice. Malat1, an upregulated Tcf4(+/)
DEG and non-coding RNA that is downregulated after training,
is similarly unresponsive to SAHA. In addition, both Arc and
Malat1 respond to training at similar levels in WT or Tcf4(+/)
mice, demonstrating that their function as memory-associated
genes is not impaired. Several Tcf4(+/) DEGs with expression
unaffected by training had their expression levels rescued by
SAHA (Figure 5E). Lefty1 and Wbscr17, both downregulated in
Tcf4(+/) mice, are upregulated by SAHA after training. Many
extracellular matrix genes were identified as downregulated
in Tcf4(+/) mice, and the upregulated expression of two
collagen subunits, Col6a1 and Col23a1, was ameliorated by
SAHA (Figure 5E).
These data also reveal a class of Tcf4(+/) DEGs dysregulated
after experiential learning but not identified as dysregulated at
baseline. Fos, a transcription factor and IEG associated with
memory formation in the hippocampus (Countryman et al.,
2005), and Tet2, a member of the 5-methyl cytosine hydroxylase
family of TET enzymes that control active DNA demethylation
that is downregulated after training (Kaas et al., 2013), are both
overexpressed in Tcf4(+/) mice compared to WT controls (Fig-
ure 5E). Npas4 and Dusp1 are IEGs that are upregulated after
training (Figure 5F). While these genes do not have dysregulated
expression in the naive Tcf4(+/) groups compared to naive
WT controls, they are expressed at relatively higher levels in
Tcf4(+/) mice after training.
Many genes with altered expression after training are similarly
affected by SAHA administration. Of the 712 genes with altered
expression due to SAHA treatment, 347 overlap with the trained
gene list (p = 1.1 3 10225). In most cases, SAHA drives the
expression, increased or decreased, in the same direction thatval post-training. Tcf4(+/) micewere trained using the trace threat recognition
fore being test again for remote memory recall.
first 2 minutes of the cue presentation.
ce.
< 0.05, **p < 0.01, ***p < 0.001.
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these genes respond to training (Figure 5G). We find this result
fascinating given the wide applicability of SAHA as a cognitive
enhancing drug in animal models, and the degree of overlap be-
tween the SAHA and the trained datasets is even more remark-
able when considering that we are examining just one time point
after threat recognition training. Genes with expression altered
by training that are also differentially expressed between the
Tcf4(+/) trained vehicle and the WT trained vehicle, notably
Npas4 and Dusp1 (Figure 5F), are also significantly affected
by SAHA in Tcf4(+/) mice. Of the 560 genes differentially
expressed between Tcf4(+/) and WT mice after training, 102
genes are significantly altered in the Tcf4(+/) trained SAHA
group (Figure 5H), many of which are memory-associated genes
(Figure 5H, filled dots). This predominately inverse relationship
demonstrates how SAHA ameliorates the expression of mem-
ory-associated genes that are dysregulated in Tcf4(+/) mice
shortly after training, and it identifies a list of genetic targets
through which SAHA may act to improve learning and memory
in Tcf4-deficient mice.
To identify genes with highly significant regions of altered CpG
methylation, Fischer’s meta-analysis was performed, combining
the power of the original Tcf4(+/) MBD-seq experiment with
that of the Tcf4(+/) naive vehicle group compared to WT con-
trols. This method identified 707 reproducible and highly signifi-
cant Tcf4(+/) DMRs that reside within annotated genes. It is
also known that experiential learning induces changes in DNA
methylation, and we identified 314 DMRs associated with genes
when comparing theWT trained vehicle and theWT naive vehicle
datasets (Table S7). Changes in CpG methylation incurred
by Tcf4(+/) had significant overlap with loci that had differential
CpG methylation induced by training for both WT and Tcf4(+/)
trained groups (Figure 6A). Unlike SAHA-treated WT mice,
which had almost no changes in CpG methylation compared
to vehicle controls, SAHA-treated Tcf4(+/) mice had 88
gene-associated DMRs that also overlapped significantly with
Tcf4(+/) DMRs.
An important question to address is whether these identified
changes in CpG methylation at genes are associated with
changes in transcription. Figure 6B shows the cross-comparison
of the DEGs and DMRs for each of the seven most relevant pair-
wise comparisons, with all significantly overlapping datasets
displaying the number of genes in common on the correspond-
ing list of DEGs and gene-associated DMRs. There are several
significant associations, notably for changes in expression andFigure 5. Effects of SAHA on Tcf4(+/) and Memory-Associated Gene
(A) Tcf4(+/) and WT mice were treated with SAHA or vehicle control for 10 days a
were then isolated from the CA1 region of the hippocampus 1 hr after training.
(B) Correlation between the original Tcf4(+/) RNA-seq and the Tcf4(+/) naive
(C) Expression of all genes in the WT naive vehicle group, and significant change
(D) Chord diagram showing the number of overlapping DEGs between each of the
significant overlaps in gene identity between comparisons are filled with color, a
(E) Expression profiles of Tcf4(+/) DEGs for select datasets.
(F) RNA-seq read density and normalized expression for the dysregulated IEGs N
(G) SAHA elicits an expression profile similar to that of training in WT mice. Scatte
WT naive vehicle. Only genes significant in both comparisons are shown.
(H) SAHA normalizes the expression of Tcf4(+/) DEGs post-training. Scatterplot
versus Tcf4(+/) trained vehicle. Only genes significant in both comparisons are
All data shown are means ± SEM from three mice per group at 2 months of age.
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lists, but the highest degree of overlap is between trained
DEGs and Tcf4(+/) genes containing DMRs (p = 9.6 3 104).
CpG methylation is often an inhibitory epigenetic mark with
distinct patterns of methylation between genes that are ex-
pressed and those that are silenced (Figure 6C). These data
also demonstrate a difference in methylation patterns around
genes that are upregulated post-training versus genes that are
downregulated, with upregulated genes having significantly
greater levels of gene body CpG methylation, despite similar
methylation levels at the TSS, compared to downregulated
genes (Figure 6D). Given that Tcf4(+/) DMRs are disproportion-
ally associated with trained DEGs, it was expected that methyl-
ation patterns around these genes would be systematically
altered. There is global demethylation of upregulated trained
DEGs in the Tcf4(+/) group but no significant difference in the
methylation patterns around genes that are downregulated after
training. The demethylation of these upregulated trained DEGs
correspond with the general trend that these genes exist in a
state of increased expression at baseline in Tcf4(+/) hippocam-
pal tissue (Figure 6E).
Hdac2 Knockdown Is Sufficient to Rescue Learning and
Memory
SAHA, likemany small-molecule HDAC inhibitors, has promiscu-
ous HDAC subtype selectivities. To identify SAHA’s functional
target for improving learning and memory in the Tcf4(+/) sys-
tem, an interactome network was created based on the original
Tcf4(+/), Tcf4(+/) naive vehicle, and Tcf4(+/) trained vehicle
DEGs versus WT controls (Breuer et al., 2013). This network of
gene product interactions (Figure 6F) identifies nodes, individual
proteins that have a high degree of interconnectivity between
and within the list of DEGs, to identify key pathways of dysregu-
lation. For the Tcf4(+/) system, it is therefore not surprising that
Tcf4 is identified as a top node of dysregulation that is downre-
gulated overall (Figure 6G). The top downregulated node is
Ubc, a polyubiquitin precursor gene. Ubc is interesting given
the similarities in phenotype between PTHS and Angelman syn-
drome, caused by mutations in the ubiquitin ligase Ube3a. The
top upregulated node is Hdac2, an HDAC isoenzyme that is
present in high levels in the CNS and has previously been impli-
cated as an epigenetic modifier that plays an important role in
regulating synaptic plasticity and memory formation (Guan
et al., 2009). We hypothesized that upregulation of Hdac2 andExpression
nd either kept naive or trained in threat recognition. RNA and methylated DNA
vehicle group DEG lists relative to WT controls.
s in transcription associated with training.
sevenmost relevant pairwise comparisons among the eight datasets. Themost
nd the significance of the overlap is listed on the perimeter.
pas4 and Dusp1.
rplot of WT naive SAHA versus WT naive vehicle and WT trained vehicle versus
of Tcf4(+/) naive vehicle versus WT naive vehicle and Tcf4(+/) trained SAHA
shown.
*p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 6. Tcf4(+/) DMRs Are Associated with Trained DEGs
(A) Chord diagram showing the number of overlapping genes containing DMRs between each of the seven most relevant pairwise comparisons among the eight
datasets. The most significant overlaps in gene identity between comparisons are filled with color, and the significance of the overlap is listed on the perimeter.
(B) Cross-comparison of DEGs and genes containing DMRs for each pairwise comparison, in which significant overlaps (p < 0.05) between datasets are shown as
circles in the matrix.
(C) Differential CpG methylation profile of expressed and silenced genes in the hippocampus of WT mice. Curve thickness is ±SEM.
(D) Differential CpG methylation profile of genes upregulated and downregulated after training. Genes upregulated after training in WT mice are significantly
hypomethylated in Tcf4(+/) mice.
(E) Geneswith significantly upregulated expression after training inWTmice have significantly increased baseline expression in Tcf4(+/) naivemice compared to
WT naive controls.
(F) Interactome network derived from the original Tcf4(+/), Tcf4(+/) naive vehicle, and Tcf4(+/) trained vehicle DEGs, highlighting gene products with a high
degree of interaction among these Tcf4(+/) DEGs.
(G) Ubc and Hdac2 are identified as the most interconnected gene products in the Tcf4(+/) DEG datasets.
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associated genes in the Tcf4(+/) system could be driving the
behavioral deficits in learning and memory and HDAC2 protein
could be the functional target of SAHA to rescue those behaviors
in Tcf4(+/) mice. To test this idea, we designed antisense oligo-
nucleotides (ASOs) to selectively target Hdac2.
Phosphorothioate and 20-O-methoxyethyl (20-MOE) modified
ASOs have been shown to elicit selective and prolonged RNA
knockdown, remain active in the CNS for several months,
and rescue deficits in mouse models for Angelman syndrome
and Huntingdon’s disease (Kordasiewicz et al., 2012; Meng
et al., 2015) through hybridization and degradation of target
RNA by recruitment of RNase H (Wu et al., 2004). To test
whether Hdac2 could be a therapeutic target for improving
cognition in PTHS, approximately 500 ASOs were designed
against the full rat Hdac2 gene, with higher density of ASOs
targeting exonic regions (Figure S7), and were evaluated for
Hdac2 knockdown at L2-RYC cells. The most active ASOs
were taken into a four-point dose response in L2-RYC cells,
and five of the most potent ASOs that were complementary
to mouse Hdac2 were injected intracerebroventricularly (ICV)
into C57BL/6 mice at a dose of 300 mg. Two weeks after
dosing, RNA was extracted from cortex, hippocampus, and
spinal cord and Hdac2 RNA reduction was measured by
qPCR (Figure S7).
HDAC2-ASO1, which targets the 30 UTR (30 UTR) of Hdac2,
was chosen from the screen and administered to the CNS of
2-month-old Tcf4(+/) mice through a single ICV injection to
the lateral ventricle, along with WT and control ASO groups,
before entering a behavioral battery (Figure 7A). As was similarly
observed with the treatment of SAHA, there was no effect on ac-
tivity or anxiety due to Hdac2 knockdown in the open field (Fig-
ures 7B and 7C); however, HDAC2-ASO1 significantly improved
performance in each of the three memory tasks we evaluated. In
OLM, HDAC2-ASO1-treated Tcf4(+/) mice showed highly sig-
nificant improved discrimination for the object placed in the
novel location (Figure 7D). HDAC2-ASO1-treated Tcf4(+/)
mice also showed improved training and significantly increased
target quadrant localization and platform crossings in the MWM
(Figures 7F–7H). Lastly, HDAC2-ASO1-treated Tcf4(+/) mice
demonstrated improved contextual threat recognition 24 hr after
training compared to a control ASO (Figure 7E), meaning that in
all three paradigms, the behavior of treated Tcf4(+/) mice was
rescued to the level of that of WT control ASO. HDAC2-ASO1-
treated WT mice show significantly improved 24 hr OLM, sug-
gesting that Hdac2 knockdown improves cognition in some
tasks outside of the Tcf4(+/) system, as has been found with
the extinction of recent memories (Gra¨ff et al., 2014).
Hippocampi were harvested 3 months after ICV injection, and
RNA was extracted to confirm knockdown of the Hdac2 mes-
sage and protein (Figure 7I; Figure S7). Hdac2 expression was
knocked down 55% in both WT and Tcf4(+/) mice treated
with HDAC2-ASO1, whileHdac1 expression was notmeasurably
affected. One explanation as to how Hdac2 inhibition might
rescue memory in Tcf4(+/) mice is by the upregulation of
Tcf4 expression directly, because subchronic SAHA upregu-
lated some Tcf4 transcripts, and Tcf4(+/) mice treated with
HDAC2-ASO1 had significantly increased Tcf4 expression in
the hippocampus compared to control ASO. Tcf4 expression is2678 Cell Reports 16, 2666–2685, September 6, 2016not altered in cortex or cerebellum despite comparable levels
of Hdac2 knockdown (data not shown).
To determine whether Hdac2 knockdown was sufficient to
normalize the expression of candidate genes found to be dysre-
gulated by RNA-seq, the expression of Kl, Arc, Lefty1, and
Grin2a, as well as NMDAR subunit 2b (Grin2b) as a negative con-
trol, was assessed by PCR analysis (Figure 7I). Hdac2 knock-
down, like SAHA administration, was unable to significantly
affect the expression of Kl and Arc. Meanwhile, the expression
of Lefty1 and Grin2a, both downregulated at baseline and
increased by SAHA, responded to Hdac2 knockdown with
significant increases in transcription. Grin2b does not have a
putative Tcf4 binding site within its promoter, is not dysregulated
by Tcf4(+/), and is not affected by Hdac2 knockdown. Kl, Arc,
Lefty1, andGrin2a all have putative Tcf4 binding sites within 3 kb
of their TSSs, suggesting that the dysregulation of some DEGs,
such as Kl and Arc, are no longer caused by reduced Tcf4
concentration, because increasing Tcf4 expression does not
measurably affect their transcription. The expression of Tet2,
which catalyzes the removal of methyl marks from DNA and is
overexpressed in Tcf4(+/) hippocampal tissue, was also
significantly decreased by Hdac2 knockdown, as with SAHA
treatment.
However, further experimentation is necessary to determine
whether normalizing Tcf4 expression post-developmentally is
sufficient to improve cognition. One possibility is that HDAC
inhibition improves learning and memory in Tcf4(+/) mice pre-
dominately through increased histone acetylation at the Tcf4
gene locus, resulting in its increased expression. Previously
reported data demonstrate significant TSA-induced hyperacety-
lation of histone 3 at Tcf4 and an enhancer region upstream from
the TSS (Lopez-Atalaya et al., 2013). However, SAHA only
marginally increases the expression of some Tcf4 transcripts
while still providing cognitive enhancement. In addition, HDAC
inhibition has been shown to improve learning and memory
outside the Tcf4(+/) system (Gra¨ff and Tsai, 2013). HDAC inhi-
bition could be beneficial in a mostly Tcf4-independent fashion
by affecting global histone acetylation levels, and HDAC2-
ASO1 enhances H4K12 acetylation in cultured hippocampal
neurons (Figure S8) but not H3 acetylation, matching global ef-
fects observed in Hdac2 knockout hippocampal tissue (Guan
et al., 2009). Finally, one explanation as to why the effects of
HDAC inhibition are large in the Tcf4(+/) system is that TSSs
that contain Tcf4 binding sequences are acetylated by TSA to
a greater level than sites that do not.
DISCUSSION
PTHS has compelling attributes in terms of human cognitive
function, being associated with pronounced memory deficits,
autistic behaviors, and an almost complete lack of language
development. Thus, understanding the roles and function of
Tcf4 in the CNS is highly significant with respect to human lan-
guage and auditory cognition, memory function, autism spec-
trum behavior, and schizophrenia susceptibility. Despite the
clear importance of Tcf4 function in the human CNS, the basic
neurobiology of Tcf4 had previously been only sparsely studied.
Thus, for these studies, we used a genetically engineered mouse
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Figure 7. HDAC2 Knockdown Enhances Tcf4 Expression and Rescues Spatial and Threat Recognition Memory in Tcf4(+/) Mice
(A) Schematic of surgical, behavioral, and expression analysis. Mice were injection with HDAC2-ASO1 or control at 2 months of age followed by a behavioral
battery including open field (OF), object location memory (OLM), Morris water maze (MWM), and contextual threat recognition (TR). At 5 months, RNA was
extracted from the hippocampus for analysis.
(B and C) HDAC2-ASO1 has no significant effect on Tcf4(+/) hyperactivity or thigmotaxis in an open field.
(D) HDAC2-ASO1 significantly improves 24 hr object location memory in Tcf4(+/) and wild-type mice.
(legend continued on next page)
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model to assess the role of Tcf4 in memory, social interactions
and communication, hippocampal synaptic plasticity, and epi-
genomic and transcriptional regulation in the CNS. Moreover,
while it is well-established that regulation of gene transcription
is necessary for late-phase LTP and long-term memory consol-
idation, relatively few specific transcriptional regulators have
been firmly tied to these phenomena to date. Our studies add
the Tcf4 transcription factor to the emerging list of transcriptional
and epigenetic regulators relevant to CNS synaptic plasticity and
memory.
This study characterizes Tcf4(+/) mice as a model system
for PTHS, implicates Tcf4 in the regulation of gene transcription
in the CNS, and identifies HDACs, specifically Hdac2, as poten-
tial neurotherapeutic targets for PTHS. Tcf4(+/) mice demon-
strate behavior that is consistent with the cognitive and motor
dysregulation associated with PTHS. Tcf4(+/) mice exhibit sta-
tistically significant learning deficiencies in cued and contextual
threat recognition and deficits in spatial learning and memory as
tested by the MWM and OLM. Tcf4(+/) mice also demonstrate
motor and balance asymmetry, favoring their front left paw
when resting and ambulating, and have significantly reduced
hindlimb grip strength. We interpret these results as being
consistent with the learning disability and deficits in gross motor
control associated with PTHS clinically. Tcf4(+/) mice are also
averse to social interaction, and Tcf4(+/) pups (P3) elicit fewer
USVs and at lower pressures compared to WT pups, pheno-
types associated with genes connected to language impair-
ments and other ASDs. These findings broadly implicate the
Tcf4 transcription factor as a potent regulator of cognition in
the domains of learning, memory, and social interactions. More-
over, based on both these mouse studies and studies in human
PTHS patients, Tcf4 is a viable candidate as a language-associ-
ated gene.
The development of new valid targets for therapeutics target-
ing PTHS and other ASDs is a pressing biomedical issue. In our
studies, we undertook preclinical proof-of-principle studies and
evaluated whether HDAC inhibitors could ameliorate memory
deficits exhibited by a mouse model of PTHS. The rescue of
the threat recognition memory deficits observed in Tcf4(+/)
mice by treatment with SAHA has substantial implications for
PTHS and other language disorders. Besides the rescue of threat
recognition memory by subchronic SAHA treatment before
training, we observed the retrieval of a memory by SAHA treat-
ment post-training, even after the memory was already demon-
strated to be inaccessible. This is not unprecedented for HDAC
inhibitors; a similar effect of HDAC inhibition on crypticmemories
has been demonstrated in a neurodegeneration mouse model
(Fischer et al., 2007). However, the observation is decidedly idio-
syncratic. These data imply that the association between the
CS and the US could be at least temporarily consolidated and
that HDAC inhibition leads to the acquisition of the otherwise
obstructed memory trace.(E) HDAC2-ASO1 rescues 24 hr contextual threat recognition memory in Tcf4(+/
(F–H) HDAC2-ASO1 rescues spatial memory in theMWM task by increasing the tim
treated mice.
(I) PCR expression analysis.HDAC2 knockdown 3months after ICV injection boos
All data shown are means ± SEM from seven to ten mice per group at 2–5 mont
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known, and we addressed this question using unbiased next-
generation sequencing, combining MBDseq and mRNAseq
approaches. Using these approaches, we not only identified a
large number of transcriptional changes triggered by Tcf4 defi-
ciency in the CNS, but we also identified several gene targets
that had previously been functionally linked to the regulation of
synaptic plasticity and memory formation. We also used MBD-
mediated gene pull-down coupled with large-scale parallel
sequencing approaches to identify candidate genes with dysre-
gulated CpG methylation in PTHS. This aspect of our studies
wasmotivated by the discovery of a role for epigenetic molecular
mechanisms in synaptic plasticity, learning, and memory (Day
et al., 2015). An emerging idea is that the regulation of chromatin
structure, mechanistically via histone modifications and direct
chemical modification of DNA, contributes to long-lasting
behavioral change. Our observations of epigenetic and tran-
scriptional alterations regulated by loss of Tcf4 function are
consistent with this fundamental hypothesis of a role for DNA
methylation in regulating memory and cognition both in labora-
tory mouse models and in human PTHS patients.
Specifically, a set of genome-wide sequencing experiments
of hippocampus-derived mRNA and methylated DNA from
Tcf4(+/) and WT naive mice, before or shortly after threat
recognition training and with or without SAHA treatment, was
performed to identify genes with altered transcription and DNA
methylation following experiential learning and/or SAHA admin-
istration. These data provide insight into the transcriptional
regulation of memory formation by identifying the following:
genes recruited 1 hr after experiential learning (memory-associ-
ated genes), increased CpG methylation at genes upregulated
compared to downregulated after learning, SAHA as amodulator
of memory-associated gene expression, and how these mecha-
nisms are altered in the Tcf4(+/) system and relate to PTHS.
Tcf4(+/) causes dysregulation in the expression of neurorecep-
tors, including Grin2a; activity-dependent genes, such as Arc,
Dusp1, Egr2, Fos, and Npas4; and regulators of synaptic plas-
ticity, such as Kl. In addition, the epigenetic modifier Tet2 was
found to be relatively overexpressed after training compared to
WT controls. Our data also revealed that Tcf4(+/) causes
decreased CpG methylation at genes with upregulated tran-
scription following experiential learning and that these mem-
ory-associated genes were correspondingly upregulated at
baseline in Tcf4(+/) mice. Tcf4 may govern the methylation of
genes with increased transcription after learning through the
negative regulation of Tet2 expression, shown to be associated
with the demethylation of gene bodies (Huang et al., 2014), or the
demethylation of memory promoting genes could be a compen-
satory mechanism. SAHA causes a significant increase in gene
body methylation in Tcf4(+/) but not WT mice, which corre-
sponds with a blunting of transcription for these genes post-
training (Figure 5H).) treated mice.
e spent in the target quadrant and the number of platform crossing in Tcf4(+/)
ts Tcf4 transcription and normalizes the expression of Lefty1,Grin2a, and Tet2.
hs of age. #p = 0.052, *p < 0.05, **p < 0.01, ***p < 0.001.
Using the catalog of sequencing experiments presented here,
we then generated an interactome network to identify key dysre-
gulated pathways in the Tcf4(+/) model system. This led to the
identification of upregulated Hdac2 activity, as well as gene
products known to interact withHdac2. To test whether a reduc-
tion of HDAC2 protein was sufficient to improve learning and
memory in Tcf4(+/) mice, 500 ASOs targeting the Hdac2 locus
were design and evaluated. A single ICV injection of a long-last-
ing HDAC2 ASO was found to be sufficient to rescue spatial
memory in the OLM and MWM tasks, as well as threat recog-
nition memory to WT levels. In addition, Hdac2 knockdown
normalized the expression of Tcf4(+/) DEGs, such as Grin2a,
Tet2, and Lefty1, as well as directly increasing Tcf4 expression.
Lastly, it was found that Tcf4(+/) causes enhancement of LTP
at Shaffer collaterals in the CA1 area. This is not novel for models
with impaired memory (Gu et al., 2002); however, the obser-
vation that HDAC inhibition attenuates LTP in the Tcf4(+/) hip-
pocampus is unprecedented. Prior genome-wide expression
analysis revealed increased Kl results in enhanced LTP and
alters NMDAR subunit composition by upregulating Grin2b and
ramping up theGrin2b/Grin2a rheostat (Dubal et al., 2014), which
decreases over the course of CNS development and has been
shown to play a role in governing decreased excitability of hip-
pocampal neurons post-learning (Abraham, 2008; Liu et al.,
2004; Yashiro and Philpot, 2008). Because Grin2a-containing
NMDARs produce shorter currents compared to those with
Grin2b andNMDAR activation is necessary for the establishment
of LTP and some forms of LTD, the ratio ofGrin2b/Grin2a is seen
as a mechanism by which a neuron can modulate its intrinsic
excitability. Tcf4 was shown to be a regulator of intrinsic
excitability in cortical neurons (Rannals et al., 2016). The phar-
macological normalization of LTP via HDAC inhibition and
the significant increase in Grin2a expression by both SAHA
treatment and Hdac2 knockdown, coupled with the rescue of
learning and memory phenotypes in Tcf4(+/) mice, strongly
support the potential of using neuroepigenetic therapies, specif-
ically targeting HDAC activity, for the treatment of PTHS.
The observed therapeutic effects of HDAC inhibitors post-
developmentally in young adult mice suggest a shift in thinking
about neurodevelopmental disorders such as PTHS. The genetic
basis of PTHS is mutation or deletion of the Tcf4 gene and resul-
tant disruption of normal Tcf4 transcription factor function. Tcf4
is present throughout development and is present in the fully
developed adult CNS. However, it is unclear whether PTHS is
caused exclusively by disruption of Tcf4 function during devel-
opment or whether loss of Tcf4 in the mature CNS might also
contribute to neurobehavioral and cognitive dysfunction in
PTHS patients. Data from studies of a number of different devel-
opmental disorders, such as Rett, Angelman, and fragile X
mental retardation, have begun to suggest that loss of normal
gene function in the post-developmental nervous system con-
tributes to cognitive and neurobehavioral dysfunction in these
disorders. Our finding of ameliorative effects of HDAC inhibition
post-developmentally in our PTHS mouse model is consistent
with this line of thinking concerning Tcf4 function in the CNS.
In summary, Tcf4 is a transcription factor that remains enig-
matic, and its precise roles in schizophrenia, autism, and
cognition are yet unclear. However, the present study shedsconsiderable light onto the basic underlying neurobiology and
biochemistry of Tcf4 haploinsufficiency. Moreover, we provide
evidence that certain cognitive aspects of PTHS can be amelio-
rated, even post-developmentally, through a neuroepigenetic
therapy such as HDAC inhibition. This study also implicates
epigenetic mechanisms regulated by Tcf4, specifically DNA
methylation and histone acetylation, in governing CNS plasticity
and major subdomains of cognitive function, including memory,
social interactions, and auditory communication.
EXPERIMENTAL PROCEDURES
All experiments were performed and analyzed by those unaware of genotype
or treatment.
Tcf4(+/) Mice
Heterozygousmale B6;129-Tcf4tm1Zhu/J mice were acquired from The Jack-
son Laboratory (stock #013598) and breed with female B6129SF1/J mice
(stock #101043) to produce Tcf4(+/) and WT littermates. All experiments
were performed on male mice between 2 and 3 months of age, unless other-
wise noted. All procedures were performed with Institutional Animal Care and
Use Committee (IACUC)-approved protocols and conducted in full compli-
ance with the Association for Assessment and Accreditation of Laboratory
Animal Care (AAALAC).
Behavior
Open Field
Open-field behavior was examined for 30 min using the infrared photobeam
Med Associates system for mice.
Elevated Plus Maze
Elevated plus maze behavior was examined for 5 min using the near-infrared
backlit maze for mice from Med Associates.
Dynamic Weight Bearing
Animals were allowed 10 min to habituate undisturbed in the commercially
available dynamic weight bearing device (Bioseb). Following this habituation
period, 3 min of video was recorded and analyzed by the connected computer
program (Advanced Dynamic Weight Bearing software; Bioseb). Three states
were differentiated (four paws, three paws, and rearing on two paws), and re-
cordings of the surface area (in square millimeters) and weight (in grams)
applied to each paw in contact with the sensor pad during this posture were
automatically computed.
CatWalk
Static and dynamic locomotor activity were assessed using the CatWalk gait
analysis system (CatWalk 9.1; Noldus Information Technology), as previously
described (Hetze et al., 2012). Briefly, the animals traversed an elevated glass
walkway (130 3 21.5 3 0.6 cm) encased with dark plastic walls spaced 5 cm
apart in a darkened room. Red fluorescent light illuminates the walkway, and
green light enters at the edge of the glass plate and is internally reflected within
the glass walkway. Scattering of the light occurs when the paw surface con-
tacts the glass walkway, thereby producing paw prints. Recordings of paw
prints were made with a high-speed camera mounted underneath the glass
walkway and analyzed on a connected computer. Mice were allowed three
training trials on one training day before assessment. For experimental inclu-
sion, animals were required to make three full passes on the instrument (two
right to left and one right to left) on the training day. The average of three
compliant trials (minimum duration, 0.5 s; maximum duration, 5.0 s; maximum
speed variation, 60%) on the testing day (two traveling from right to left and one
from left to right) was found from the data. Data were analyzed using CatWalk
9.1 software. The >190 parameters analyzed (previously described by Hamers
et al., 2006) included those describing individual paws, paw print positioning,
and the temporal relationship between paw prints. Significant findings are
reported in Figure S1 and include definitions of each gait parameter.
Grip Strength
Neuromuscular function of the forelimbs and hindlimbs was tested with a grip
strength meter (San Diego Instruments). To assess forelimb grip strength, theCell Reports 16, 2666–2685, September 6, 2016 2681
meter was positioned horizontally, the mice were held by the tail and lowered
toward the apparatus, and then they were allowed to grasp the smooth metal
grid (forelimbs only) and were pulled backward in the horizontal plane. To
assess hindlimb grip strength, we scruffed the mice by the back of the neck,
held them by the tail, and lifted them into an upright position. Then, the mice
were lowered toward the apparatus, allowed to grasp the smooth metal grid
(hindlimbs only), and pulled backward in the horizontal plane. The force
applied to the grid at the moment the grasp was released was recorded as
the peak tension (in newtons) and normalized to the animal’s weight. Grip
strength was measured in triplicate and averaged.
Horizontal Ladder
Motor ataxia was assessed with a commercially available horizontal ladder
(Bioseb). Mice were allowed three training trials on three separate training
days. For experimental inclusion, animals were required to cross the ladder
in under 90 s on a minimum of two training trials on the final training day.
Data from the final testing day are the average of two trials.
Rotating Rod
Grossmotor coordination andmemory were assessed by the ability to balance
on a rotating and progressively accelerated rod. Using a Five Station Rota-Rod
Treadmill (Med Associates), latency to fall was measured over a 5 min trial
window as the rod was lineally accelerated from 4 to 40 rpm. Four trials
were performed each day, with a minimum of 1 hr between trials, for a total
of 12 trials.
Social Interaction
The three-chamber social interaction test consists of a 403 50 cm field made
of opaque polyurethane divided into three equally proportioned chambers by
clear plastic walls with a 53 5 cm passage between them, with two equivalent
distal chambers and one center chamber linking them together. The two distal
chambers each contain a single cylindrical steel cage, one of which holds a
novel mouse and the other of which is empty. The test mouse is habituated
to the chamber and steel cages for 10 min before testing (Figure S2). Then,
a novel mouse is placed in out of the two cages at random, the test mouse
is reintroduced to the center chamber, and the time spent in each chamber
is recorded over a 10 min trial.
Grooming
Mice were placed in an empty home cage with fresh bedding and allowed to
habituate for 10 min. Then, they were observed for a 10 min block and the
time spent grooming was recorded.
Startle Reflex and Prepulse Inhibition
The startle response to 120 dB white noise and its inhibition by a prepulse was
examined using the Acoustic Startle Reflex Package for mice from Med Asso-
ciates. A 4 kHz prepulse was presented 0, 4, 8, and 16 dB above a 65 bD back-
ground white noise.
USVs and Distress Calls
Pups (P3, P5, P7, P9, and P11) were removed from the home cage and placed
into a soundproof chamber, and USVswere detected over a 5min period using
an Ultrasonic Vocalization Detector from Med Associates. Ultrasonic distress
calls were elicited by lifting and holding the pup by hand for 30 s after the 5 min
USV detection period.
OLM
Mice were trained for 10 min with two 50 ml beakers and one black line spatial
cue in a 10 3 10 3 12 in (x, y, z) opaque polyurethane open box containing
autoclaved bedding. Before training, mice were habituated to the box and
bedding without objects for 4 days, 5 min each day. Then, 24 hr after training,
one beaker was moved to a novel location and the mice were tested for 5 min.
Videos were scored by hand and blind to subject identity, and object interac-
tion was scored as previously described (Haettig et al., 2011).
MWM
Mice were trained in a 135 cm diameter pool made opaque with water-soluble
non-toxic white paint and a square 103 10 cm platform placed 27 cm from the
northwest wall of the pool and submerged 5–7 mm below the surface of the
water. Four distinct visual cues were placed on the north, south, east, and
west walls. Mice were trained with four trials a day (block), separated by 1 hr
between trials, for a total of 4 days. Mice were placed in the pool at four points,
randomly for each trial, and latency to find the platform was measured. Then,
24 hr after the final day of training, the platformwas removed from the pool and
micewere test in a 60 s trial for time spent in the quadrant previously containing2682 Cell Reports 16, 2666–2685, September 6, 2016the platform (target quadrant) and the number of times the mouse swam over
the exact location of the platform (platform crossings). Finally, the spatial cues
were removed from the wall and a small visual cue (6 inch flag) was placed
directly on the platform. Eight trials of visible-platform training (four trials per
day) were conducted, and latencies to the platform were recorded.
Threat Recognition
Training consisted of a 2 min habituation period followed by three 20 s, 80 dB
white noise cues (CS) spaced 100 s apart and each followed 15 s later by a 1 s,
0.5 mA foot shock (US). The animals remained in the chamber for an additional
minute before being returned to their home cage. For the 24 hr contextual test,
mice were reintroduced to the training chamber for 5 min. For the 24 hr cue
test, mice were introduced to a novel context and allowed to habituation for
2 min before a 3 min, 80 dB white noise (CS) was presented. The percentage
of freezingwas calculated over the 3min presentation period, unless otherwise
noted.
Experimental Manipulations
SAHA Administration
SAHA (vorinostat, Zolinza) was purchased from TCI America, dissolved in
vehicle (10% DMSO in saline), and administered at 25 mg/kg once per day
i.p. for 10 days before behavioral assessment or tissue extraction. On the
day of behavioral assessment, SAHA was injected 2 hr before entering the
open field or threat recognition paradigms.
SAHA-Mediated Remote Memory Retrieval
Tcf4(+/) mice and WT controls were trained and tested for 24 hr trace threat
recognition before each genotype was split into two parametrically similar
groups receiving either SAHA or vehicle for 10 days, beginning 24 hr after
the first cue test. Then, 11 days after the initial training, mice were submitted
to a second cue test.
HDAC2-ASO Identification and Administration
HDAC2-ASO (50-CToCoAoCTTTTCGAGGTToCoCTA-30 ) and control-ASO
that targets no mouse or human genes (50-GToToToTCAAATACACCToTo
CAT-30) were generated by ISIS Pharmaceuticals using the phosphorothioate
and 20-MOE modified ASO platform. C, T, A, and G indicate 5-methylcytosine,
thymine, adenine, and guanine nucleosides, respectively. Underlined residues
are deoxynucleosides; all others are 20-MOE nucleosides. All linkages are
phosphorothioate except those indicate by ‘‘o’’ between residues, which are
phosphodiester. Briefly, approximately 500 ASOs were designed against the
full rat HDAC2 gene, with a higher density of ASOs targeting exonic regions.
ASOs were electroporated into L2-RYC cells at a concentration of 5 mM,
and RNA was extracted 24 hr after treatment for quantification. The most
active ASOs were taken into a four-point dose response in L2-RYC cells,
and five of the most potent ASOs that were complementary to mouse
HDAC2 were injected by ICV bolus into C57BL/6 mice at a dose of 300 mg
(n = 4). Two weeks after dosing, RNA was extracted from cortex, hippocam-
pus, and spinal cord, and HDAC2 RNA reduction was measured by qPCR.
The most active ASO (ASO1) was injected into C57BL/6 mice (700 mg ICV,
n = 4), which were followed for 8 weeks post-treatment. At 8 weeks, mice
were sacrificed and HDAC2 RNA was measured. For ICV injections, mice
were anaesthetized with 2% isoflurane and secured in a stereotaxic frame (Da-
vid Kopf Instruments). ASOs were diluted to 60 mg/ml in saline and injected
15 mg/kg ICV into the lateral ventricle (anterior/posterior [A/P], 0.2; medial/
lateral [M/L], 1.0; dorsal/ventral [D/V], 2.4 to the bregma) of 2-month-old
mice at a rate of 1 ml/min. After the injection, the needle was kept in place
for 5 min before its removal, followed by suturing of the incision.
Gene Expression Analysis
For RNA sequencing, the hippocampus was extracted from 2-month-old mice
(four animals per genotype) and the CA1 region was subdissected. Total
mRNA was extracted (RNeasy, QIAGEN), quality controlled (Bioanalyzer, Agi-
lent), and poly(A) selected and sequenced (HudsonAlpha) on the Illumina plat-
form (HiSeq v.4, paired end, 50 bp, 50 million reads). Reads were filtered by
quality (90% of all bases were required to have a quality score > 20) and map-
ped using Tophat (maximum realign edit distance = 1,000, maximum edit dis-
tance = 2, maximum mismatches = 2, anchor length = 8, minimum intron
length = 70, maximum intron length = 500,000) to the mm10 genome. Gene
expression (fragments per kilobase per million [FPKM]) was calculated using
Cufflinks, and DEGs were called by Cuffdiff, performing quartile normalization
and using per-condition variances at a FDR < 0.05, and annotated with the
NCBI refseq database. KEGG pathway and phenotypic analysis were per-
formed using the free online WebGestalt software (http://bioinfo.vanderbilt.
edu/webgestalt/). The Interactome network was derived from the original
Tcf4(+/), Tcf4(+/) naive vehicle, and Tcf4(+/) trained vehicle DEGs
compared to WT controls using the free online NetworkAnalyst software
(http://www.networkanalyst.ca/).
qRT-PCR was performed using standard procedures with exon-specific
primers. Total mRNA was reverse transcribed using the iScript cDNA Synthe-
sis Kit (Bio-Rad). qPCR was performed with the CFX96 Optical Reaction
Module system (Bio-Rad) using SYBR green (Bio-Rad) with the following
primers. Relative gene expression was determined using the comparative
computed tomography method (Livak and Schmittgen, 2001) and normalized
toGapdh levels.Hdac1 (Mm02391771_g1),Hdac2 (Mm00515108_m1),Grin2a
(Mm00433802_m1), Grin2b (Mm00433820_m1), Arc (Mm01204954_g1), and
Kl (Mm00502002_m1) expression was detected using TaqMan Gene Expres-
sion Assays (Life Technologies) and normalized to the expression levels of
Gapdh (Mm99999915_g1).
CpG Methylomics Analysis
For CpG dimethylation sequencing (MBD-seq), the hippocampus was ex-
tracted from 2-month-old mice (three animals per genotype) and the CA1 re-
gion was subdissected. Double-stranded DNA was extracted (DNeasy,
QIAGEN) and sonicated to an average length of 300 bp as determined by
gel electrophoreses. Methylated DNA fragments were then sequestered using
the MethylMiner Methylated DNA Enrichment Kit (Life Technologies). The
methylated DNA was then sized selected between 200 and 400 bp, amplified
by PCR, and sequenced (HudsonAlpha) on the Illumina platform (HiSeq v.4,
single end, 50 bp, 25 million reads).
Reads were trimmed (2 nt from the 50 end), and PCR duplicates were
removed (10.7 million to 22.6 million novel reads per sample) and mapped
with Bowtie for Illumina to the mm10 genome. DMRs were then called using
the published MEDIPS package and the R statistical programming language
(window size [ws] = 300, extend = 300, shift = 0, uniq = T, quantile normalized,
FDR = 0.1) (Lienhard et al., 2014).
Bisulfite Sequencing
Genomic DNA was extracted (DNeasy Blood and Tissue Kit, QIAGEN), treated
with RNase A, and quantified (Quant-iT dsDNA HS Kit, Invitrogen) using the
manufacturer’s recommended protocols. Then, 450 ng of DNA per sample
underwent bisulfite conversion (EZ DNA Methylation Kit, ZymoGenetics)
and PCR amplification using bisulfite-compatible primer sets targeting the
following three loci: chromosome (chr) 5, 131,050,501–131,050,800; chr4,
155,716,201–155,716,500; and chr8, 29,059,501–29,059,801. PCR products
were cloned using the TOPO-TA cloning system (Invitrogen) and transformed
into Stbl3s (Invitrogen). Individual colonies were sequenced using Sanger
sequencing (UAB Heflin Genomics Core). For each group, 20 individual clones
were sequenced.
Cell Culture
Cultures were prepared from embryonic day 16 mouse hippocampal tissue.
Briefly, 12-well tissue culture plates (Corning Life Sciences) were coated over-
night at 37C with poly-L-lysine (50 mg/ml) (Sigma-Aldrich) and rinsed two
times with diH2O. Hippocampal tissue was dissected in Hank’s balanced
salt solution (Life Technologies), digested in papain (Worthington Biochem-
ical), and dissociated with fire-polished glass pipettes in Neurobasal medium
(Life Technologies) supplemented with L-glutamine and B-27 (Life Technolo-
gies). The cell suspension was filtered through a 70-mmcell strainer and centri-
fuged. Cells were resuspended in the supplemented Neurobasal medium at a
concentration of 125,000 cells/ml and plated. Cells were grown in a humidified
CO2 (5%) incubator at 37
C. Half of the mediumwas changed at 2 days in vitro
(DIV) and every 4 days thereafter. RNA and protein were collected at 19 DIV
following drug treatments. Treatments of hippocampal cultures were done at
the following final drug concentrations: 10 mM control ASO and 10 mM
HDAC2 ASOs. ASOs were added at 2 DIV and after every media change. Cells
were harvested at 21 DIV.Antibodies
Anti-histone H3 antibody (#3638, Cell Signaling Technology), anti-acetyl-his-
tone H3 antibody (06-599, Millipore), anti-acetyl-histone H4 (Lys12) antibody
(04-119, Millipore), and anti-actin antibody (ab3280, Abcam) were used.
E-Box Motif Analysis
Genes containing putative Tcf4 binding sites surrounding their TSSs
were identified using MotifMap (Daily et al., 2011). E-box sequences
(50-NCASCTGBYNYNKN-30, 50-CABCTGBY-30, and 50-RRCAGGTGBHV-30)
were identified at FDR < 0.05, normalized log odds > 0.65, and within
3 kb of annotated TSSs. A full list of genes can be found in Supplemental
Information.
H3K9,14 and H4K12 ChIP-Seq Data Analysis
Using publically available data (GEO: GSE44868), differential histone
acetylation levels of TSA-treated versus vehicle-treated mouse hippo-
campal tissue were assessed by mapping Fastq files generated from
H3K9,14Ac and H4K12Ac chromatin immunoprecipitation sequencing
(ChIP-seq) with Bowtie for Illumina to the mm10 genome. Tcf4 locus
acetylation patterns were generated by plotting differential wiggle plots
(reads per kilobase per million [RPKM], 300 nt windows) of the TSA-
treated samples versus the vehicle-treated samples. TSS acetylation
levels were determined by quantifying read densities (RPKM) ±3 kb around
TSSs.
Chemoinformatics
The Tcf4 homology model was generated and rendered from the crystal struc-
ture of Tcf3 as previously described (Sepp et al., 2012) using the Molecular
Operating Environment by Chemical Computing Group.
LTP
Electrophysiology on Shaffer collaterals in the CA1 area was performed
as previously described (Feng et al., 2010). Field excitatory post-synaptic
potential (fEPSP) slopes over various stimulus intensities (1–30 mV)
were used to assess baseline synaptic transmission. Subsequent stimuli
were set to an intensity that evoked a fEPSP that had a slope of 50% or
25% of the maximum fEPSP slope. LTP was induced by theta burst stim-
ulation. Synaptic efficacy was assessed for 3 hr following stimulation by
recording fEPSPs every 20 s, and traces were averaged for every 2 min
interval.
Statistics
Statistical analyses were performed with two-way ANOVA, followed by
Tukey’s post hoc analyses, or unpaired Student’s t test using GraphPad
Prism v.6. Cumulative distributions were evaluated using a Kolmogorov-
Smirnov test. All data are represented as mean ± SEM. Statistical signifi-
cance was set at p < 0.05, with a FDR < 0.05 for Cuffdiff and FDR < 0.1
for edgeR.
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